Insider · CIK 0001181556
Arthur A Levin
Files at RNA (Avidity Biosciences, Inc.), STOK (Stoke Therapeutics, Inc.). First filing Oct 23, 2024, latest Aug 8, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNA: Avidity Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Avidity Biosciences, Inc. | $5.1M 107,500 shares | -85% | - | |
| 22Weak | Avidity Biosciences, Inc. | $54k 1,872 shares | -13% | - | |
| 11Weak | Avidity Biosciences, Inc. | $140k 3,323 shares | -18% | - | |
| 11Weak | Avidity Biosciences, Inc. | $233k 5,000 shares | -25% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | RNA Avidity Biosciences, Inc. | GGift Common Stock | -1,330 | $0.00 | $0 | 18,320 | Dec 22, 2025 |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +107,500 | $22.34 | $2.4M | 127,150 | Aug 8, 2025 |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -107,500 | $47.62 | $5.1M | 19,650 | Aug 8, 2025 |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -107,500 | $0.00 | $0 | 12,500 | Aug 8, 2025 |
| Jun 30, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +1,210 | $0.00 | $0 | 2,420 | Jul 2, 2025 |
| Jun 30, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,210 | $0.00 | $0 | 2,422 | Jul 2, 2025 |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | AGrant or award Common Stock | +6,692 | $0.00 | $0 | 19,650 | Jun 12, 2025 |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,034 | $0.00 | $0 | 10,034 | Jun 12, 2025 |
| Jun 3, 2025 | STOK Stoke Therapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +29,747 | $0.00 | $0 | 29,747 | Jun 4, 2025 |
| Mar 31, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +1,210 | $0.00 | $0 | 1,210 | Apr 2, 2025 |
| Mar 31, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,210 | $0.00 | $0 | 3,632 | Apr 2, 2025 |
| Mar 19, 2025 | STOK Stoke Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +4,842 | $0.00 | $0 | 4,842 | Mar 20, 2025 |
| Jan 21, 2025 | RNA Avidity Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -1,872 | $28.60 | $54k | 12,958 | Jan 23, 2025 |
| Nov 19, 2024 | RNA Avidity Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +3,323 | $1.24 | $4,121 | 18,153 | Nov 20, 2024 |
| Nov 19, 2024 | RNA Avidity Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,323 | $42.12 | $140k | 14,830 | Nov 20, 2024 |
| Nov 19, 2024 | RNA Avidity Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,323 | $0.00 | $0 | 0 | Nov 20, 2024 |
| Oct 21, 2024 | RNA Avidity Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $1.24 | $6,200 | 19,830 | Oct 23, 2024 |
| Oct 21, 2024 | RNA Avidity Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $46.63 | $233k | 14,830 | Oct 23, 2024 |
| Oct 21, 2024 | RNA Avidity Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 3,323 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.